Scientists test new Two-Pronged attack on tough prostate cancer
NCT ID NCT07082920
Summary
This early-stage study is testing a new combination of two experimental drugs for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapy. The main goals are to find a safe and effective dose of the two drugs used together and to see how well the body tolerates this treatment. The study will enroll about 140 participants to gather this initial safety and dosing information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
-
Royal Marsden Hospital (Sutton)
RECRUITINGSutton, SM2 5PT, United Kingdom
-
The Christie Nhs Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.